Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Exagen (XGN) Non Operating Income (2018 - 2026)

Exagen filings provide 8 years of Non Operating Income readings, the most recent being -$132000.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 183.54% to -$132000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $713000.0, a 39.78% decrease, with the full-year FY2021 number at $16000.0, down 98.37% from a year prior.
  • Non Operating Income hit -$132000.0 in Q1 2026 for Exagen, down from $158000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $476000.0 in Q2 2023 to a low of -$132000.0 in Q1 2026.
  • Median Non Operating Income over the past 4 years was $158000.0 (2025), compared with a mean of $151714.3.
  • Biggest five-year swings in Non Operating Income: skyrocketed 11200.0% in 2022 and later tumbled 183.54% in 2026.
  • Exagen's Non Operating Income stood at $339000.0 in 2022, then tumbled by 37.76% to $211000.0 in 2023, then decreased by 25.12% to $158000.0 in 2025, then tumbled by 183.54% to -$132000.0 in 2026.
  • The last three reported values for Non Operating Income were -$132000.0 (Q1 2026), $158000.0 (Q1 2025), and $211000.0 (Q3 2023) per Business Quant data.